DE3684457D1 - Organische verbindungen und ihre pharmazeutische verwendung. - Google Patents

Organische verbindungen und ihre pharmazeutische verwendung.

Info

Publication number
DE3684457D1
DE3684457D1 DE8686309402T DE3684457T DE3684457D1 DE 3684457 D1 DE3684457 D1 DE 3684457D1 DE 8686309402 T DE8686309402 T DE 8686309402T DE 3684457 T DE3684457 T DE 3684457T DE 3684457 D1 DE3684457 D1 DE 3684457D1
Authority
DE
Germany
Prior art keywords
sub
sup
alkyl
hydrogen
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686309402T
Other languages
English (en)
Inventor
Stephen Richard Baker
Alec Todd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Application granted granted Critical
Publication of DE3684457D1 publication Critical patent/DE3684457D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8686309402T 1985-12-07 1986-12-03 Organische verbindungen und ihre pharmazeutische verwendung. Expired - Fee Related DE3684457D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858530222A GB8530222D0 (en) 1985-12-07 1985-12-07 Organic compounds

Publications (1)

Publication Number Publication Date
DE3684457D1 true DE3684457D1 (de) 1992-04-23

Family

ID=10589419

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686309402T Expired - Fee Related DE3684457D1 (de) 1985-12-07 1986-12-03 Organische verbindungen und ihre pharmazeutische verwendung.

Country Status (8)

Country Link
US (1) US4845110A (de)
EP (1) EP0235452B1 (de)
JP (1) JPS62187445A (de)
AT (1) ATE73781T1 (de)
DE (1) DE3684457D1 (de)
ES (1) ES2033242T3 (de)
GB (2) GB8530222D0 (de)
GR (1) GR3004104T3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143931A (en) * 1982-06-24 1992-09-01 Smithkline Beecham Corporation Leukotriene antagonists containing tetrazolyl groups
US4939279A (en) * 1985-04-19 1990-07-03 Smithkline Beecham Corporation Leukotriene antagonists
DE3604050A1 (de) * 1986-02-08 1987-08-13 Boehringer Mannheim Gmbh Thioether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
PT87616B (pt) * 1987-06-24 1992-09-30 Smithkline Beecham Corp Processo de preparacao de antagonistas do leucotrieno e de composicoes farmaceuticas
GB8725260D0 (en) * 1987-10-28 1987-12-02 Lilly Industries Ltd Organic compounds
GB8807016D0 (en) * 1988-03-24 1988-04-27 Lilly Industries Ltd Organic compounds & their pharmaceutical use
GB2218416A (en) * 1988-05-13 1989-11-15 Bayer Ag Leukotriene disease antagonists
US5221760A (en) * 1988-05-13 1993-06-22 Bayer Aktiengesellschaft Alkenoic acid derivatives
US4954513A (en) * 1988-12-23 1990-09-04 Smithkline Beecham Corporation Leukotriene antagonists
GB9100493D0 (en) * 1991-01-10 1991-02-20 Bayer Ag Substituted alkenoic acid and its derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds
GB8432144D0 (en) * 1984-12-20 1985-01-30 Lilly Industries Ltd Organic compounds
GB8502258D0 (en) * 1985-01-30 1985-02-27 Lilly Industries Ltd Organic compounds

Also Published As

Publication number Publication date
ATE73781T1 (de) 1992-04-15
GB8530222D0 (en) 1986-01-15
GB2184121A (en) 1987-06-17
GB8628960D0 (en) 1987-01-07
GB2184121B (en) 1990-04-11
EP0235452A2 (de) 1987-09-09
ES2033242T3 (es) 1993-03-16
US4845110A (en) 1989-07-04
JPS62187445A (ja) 1987-08-15
EP0235452A3 (en) 1988-10-26
EP0235452B1 (de) 1992-03-18
GR3004104T3 (de) 1993-03-31

Similar Documents

Publication Publication Date Title
MY102762A (en) Novel organic compounds and their pharmaceutical use.
IT1308633B1 (it) Nitrossiderivati.
ES2067500T3 (es) 1-indolilalquil-4-(piridinil-sustituidas)piperazinas.
ATE76864T1 (de) Aromatische polycyclische derivate, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen und kosmetischen zubereitungen.
ES8703410A1 (es) Procedimiento para preparar guanidinas anti-inflamatorias
DE3684457D1 (de) Organische verbindungen und ihre pharmazeutische verwendung.
ES435223A1 (es) Procedimiento para la preparacion de nuevas 6-aril-4h-s-tri-azolo(3,4c)-tieno-(2,3e)-1,4-diazepinas sustituidas.
ES2000456A6 (es) Procedimiento para preparar deirvados de acido eicosatriinoico-5,8,11 y utilizacion de estos en composiciones farmaceuticas y cosmeticas.
ES2010284A6 (es) Procedimiento para preparar derivados de tiourea.
DE3682215D1 (de) Organische verbindungen und ihre pharmazeutische verwendung.
DK274086A (da) Substituerede phenyleddikesyreamidforbindelser og farmaceutisk acceptable salte heraf samt farmaceutisk komposition med antiinflammatorisk og analgetisk virkning indeholdende disse
ATE38675T1 (de) Phosphatesterderivate und ihre verwendung als anti-krebsmittel.
ATE93861T1 (de) Synthese von beta-lactamverbindungen.
GB8725260D0 (en) Organic compounds
ES2042499T3 (es) Procedimiento para preparar un derivado de acido 2-piridilacetico.
ATE38984T1 (de) Isocyanato-azetidin-dionen.
ES2014975B3 (es) Nuevas 1,4 iento para su obtencion, asi como su utilizacion como medicamentos.
DK428686D0 (da) Naphthalenderivater
ES8202554A1 (es) Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2)sustituidas
SE7809127L (sv) Allenaminer
ES8606273A1 (es) Un procedimiento para la preparacion de compuestos de 2- oxindol
DK158263C (da) Decahydroquinolinolderivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske eller veterinaere midler indeholdende disse
TH13340A (th) 2 , 3 - ไดดีออกซี - 5 - ไตรฟลูออโรเมทธิลยุรีตีนที่ถูกแทนที่ ขบวนการเตรียมและการใช้ในเภสัชภัณฑ์
TH3207A (th) อนุพันธ์ของกรดเฟนนอกซีโปรบีโอนิค
TH3123EX (th) 2-ออกซ์อินโคล-1-คาร์บอกซามีดที่ถูกแทนที่ด้วยหมู่แทนที่สองหมู่ที่ n และตำแหน่ง 3 ในฐานะเป็นสารแก้ปวดและต่อต้านการอักเสบ

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee